| Adenosine and inflammation: what's new on the horizon? L Antonioli, B Csóka, M Fornai, R Colucci, E Kokai, C Blandizzi, G Haskó Drug Discovery Today 19 (8), 1051-1068, 2014 | 187 | 2014 |
| Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders L Antonioli, R Colucci, C La Motta, M Tuccori, O Awwad, F Da Settimo, ... Current drug targets 13 (6), 842-862, 2012 | 173 | 2012 |
| Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review M Tuccori, A Testi, L Antonioli, M Fornai, S Montagnani, N Ghisu, ... Clinical therapeutics 31, 1426-1453, 2009 | 141 | 2009 |
| Inhibition of adenosine deaminase attenuates inflammation in experimental colitis L Antonioli, M Fornai, R Colucci, N Ghisu, F Da Settimo, G Natale, ... Journal of Pharmacology and Experimental Therapeutics 322 (2), 435-442, 2007 | 137 | 2007 |
| Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications L Antonioli, M Fornai, R Colucci, N Ghisu, M Tuccori, M Del Tacca, ... Pharmacology & therapeutics 120 (3), 233-253, 2008 | 133 | 2008 |
| Efficacy and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: A review M Del Tacca, R Colucci, M Fornai, C Blandizzi Clinical drug investigation 22, 799-818, 2002 | 128 | 2002 |
| Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress A Virdis, R Colucci, M Fornai, C Blandizzi, E Duranti, S Pinto, N Bernardini, ... Journal of Pharmacology and experimental therapeutics 312 (3), 945-953, 2005 | 114 | 2005 |
| Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage C Blandizzi, M Fornai, R Colucci, G Natale, V Lubrano, C Vassalle, ... World Journal of Gastroenterology: WJG 11 (26), 4052, 2005 | 99 | 2005 |
| Mechanisms of protection by pantoprazole against NSAID-induced gastric mucosal damage M Fornai, G Natale, R Colucci, M Tuccori, G Carazzina, L Antonioli, ... Naunyn-Schmiedeberg's archives of pharmacology 372, 79-87, 2005 | 88 | 2005 |
| Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by α2‐adrenoceptors in the presence of experimental colitis C Blandizzi, M Fornai, R Colucci, F Baschiera, G Barbara, RD Giorgio, ... British journal of pharmacology 139 (2), 309-320, 2003 | 88 | 2003 |
| Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting M Tuccori, F Lapi, A Testi, E Ruggiero, U Moretti, A Vannacci, R Bonaiuti, ... Drug safety 34, 849-859, 2011 | 85 | 2011 |
| Cyclooxygenase-1 Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries From Angiotensin II–Infused Mice A Virdis, R Colucci, M Fornai, E Duranti, C Giannarelli, N Bernardini, ... Hypertension 49 (3), 679-686, 2007 | 85 | 2007 |
| Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids A Virdis, R Colucci, D Versari, N Ghisu, M Fornai, L Antonioli, E Duranti, ... Hypertension 53 (6), 1008-1016, 2009 | 84 | 2009 |
| Mechanisms of gastroprotection by lansoprazole pretreatment against experimentally induced injury in rats: role of mucosal oxidative damage and sulfhydryl compounds G Natale, G Lazzeri, V Lubrano, R Colucci, C Vassalle, M Fornai, ... Toxicology and applied pharmacology 195 (1), 62-72, 2004 | 81 | 2004 |
| Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases L Antonioli, M Fornai, R Colucci, N Ghisu, M Tuccori, M Del Tacca, ... Inflammatory bowel diseases 14 (4), 566-574, 2008 | 80 | 2008 |
| Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of … M Fornai, R Colucci, L Antonioli, O Awwad, C Ugolini, M Tuccori, F Fulceri, ... Pharmacological Research 63 (1), 59-67, 2011 | 78 | 2011 |
| The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications L Antonioli, R Colucci, C Pellegrini, G Giustarini, M Tuccori, C Blandizzi, ... Pharmacology & therapeutics 139 (2), 157-188, 2013 | 73 | 2013 |
| Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice M Fornai, C Blandizzi, R Colucci, L Antonioli, N Bernardini, C Segnani, ... Gut 54 (5), 608-616, 2005 | 65 | 2005 |
| Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management M Tuccori, S Montagnani, S Mantarro, A Capogrosso-Sansone, ... Cns Drugs 28, 249-272, 2014 | 64 | 2014 |
| Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy M Tuccori, D Focosi, C Blandizzi, M Pelosini, S Montagnani, F Maggi, ... The oncologist 15 (11), 1214-1219, 2010 | 64 | 2010 |
